4//SEC Filing
Winningham Rick E 4
Accession 0001302443-25-000008
CIK 0001583107other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 7:10 PM ET
Size
9.4 KB
Accession
0001302443-25-000008
Insider Transaction Report
Form 4
Winningham Rick E
DirectorChief Executive Officer
Transactions
- Gift
Ordinary Shares
2025-11-19−9,900→ 1,707,886 total - Tax Payment
Ordinary Shares
2025-11-20$17.90/sh−56,817$1,017,024→ 1,651,069 total - Gift
Ordinary Shares
2025-11-19+9,900→ 23,400 total(indirect: As Custodian)
Holdings
- 92,567(indirect: By Trust)
Ordinary Shares
Footnotes (3)
- [F1]Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.
- [F2]The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.
- [F3]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302443
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 7:10 PM ET
- Size
- 9.4 KB